High DHCR7 Expression Predicts Poor Prognosis for Cervical Cancer

Table 1

Patients’ characteristics in the TCGA cohort.

Characters	Overall, (%)
Age (y) (median [IQR])
<=50	185 (60.8%)
>50	119 (39.2%)
Primary tumor (T)
T1	140 (46.0%)
T2	71 (23.4%)
T3	20 (6.6%)
T4	10 (3.3%)
Unknown	63 (20.7%)
Lymph node status (N)
N0	133 (43.8%)
N1	60 (19.7%)
Unknown	111 (36.5%)
Metastasis (M)
M0	116 (38.2%)
M1	10 (3.3%)
Unknown	178 (58.5%)
Radiation therapy
No	122 (40.1%)
Yes	182 (59.9%)
Primary therapy outcome
CR	181 (59.5%)
PD	22 (7.2%)
PR	8 (2.6%)
SD	6 (2.0%)
Unknown	87 (28.6%)
Histological type
Adenosquamous	52 (17.1%)
Squamous cell carcinoma	252 (82.9%)
Histologic grade
G1	18 (5.9%)
G2	135 (44.4%)
G3	118 (38.8%)
G4	1 (0.3%)
Unknown	32 (10.5%)
Clinical stage
Stage I	162 (53.2%)
Stage II	69 (22.6%)
Stage III	45 (14.8%)
Stage IV	21 (6.9%)
Unknown	7 (2.3%)
Menopause status
Peri	25 (8.2%)
Post	82 (27.0%)
Pre	124 (40.8%)
Unknown	73 (24.0%)
Birth control pill history
No	89 (56.7%)
Yes	68 (43.3%)
Keratinizing squamous cell carcinoma present
No	119 (39.1%)
Yes	185 (60.9%)
Smoker
No	144 (47.4%)
Yes	117 (38.5%)
Unknown	43 (14.1%)